News & Analysis on Clinical Trial Services & Contract Research And Development
The European monoclonal antibody therapeutics market is set to grow at a compound annual growth rate (CAGR) of 34.1 per cent to $11.4 billion (€8.7 billion) by 2011. The growth is fuelled by the need for safe and effective treatment alternatives to...
Cybio has launched a new flash luminescence reader that improves throughput and data quality in functional screening of G-Protein coupled receptors and calcium channels in drug discovery and research.
Nobex Corporation has been granted two new US patents, which expand its 'PEGylation' technology of small polyethylene glycols (PEG) for modifying molecules for improved drug performance.
According to a new report, the number of victims claimed by the South-East Asian tsunami is likely to rise due to the lack of drugs in active development for post-tsunami diseases. The report identified only 87 drugs in active development for some of...
GPC Biotech announced the initiation of a Phase I trial with its anticancer monoclonal antibody, 1D09C3, which has already proved effective in the treatment of lymphoid tumours including non-Hodgkin's lymphoma.